MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ CAPITAL |
Anteile |
15.6 M |
Marktkapitalisierung |
$ 1.09 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Reata Pharmaceuticals
RETA
|
- | - | $ 6.29 B | Nasdaq Global Market,SPB | USA |
 |
ObsEva SA
OBSV
|
- | -15.52 % | $ 10.5 M | Nasdaq Global Select Market |  Schweiz |
 |
PolarityTE
PTE
|
- | -0.82 % | $ 1.78 M | Nasdaq Capital Market | USA |
 |
Kronos Bio
KRON
|
- | 1.49 % | $ 50.8 M | Nasdaq Global Select Market | USA |
 |
Landos Biopharma
LABP
|
- | 0.58 % | $ 144 M | Nasdaq Global Market | USA |
 |
Myovant Sciences Ltd.
MYOV
|
- | -0.04 % | $ 2.62 B | NYSE | USA |
 |
Poseida Therapeutics
PSTX
|
- | - | $ 857 M | Nasdaq Global Select Market | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
- | - | $ 231 M | Nasdaq Global Market | USA |
 |
Trevena
TRVN
|
- | -46.58 % | $ 31.8 M | Nasdaq Capital Market | USA |
 |
Immunovant
IMVT
|
$ 29.9 | 2.96 % | $ 5.45 B | Nasdaq Global Select Market | USA |
 |
Virpax Pharmaceuticals
VRPX
|
- | -45.12 % | $ 2.85 M | Nasdaq Global Select Market | USA |
 |
Oncorus
ONCR
|
- | -8.54 % | $ 3.19 M | Nasdaq Global Market | USA |
 |
Y-mAbs Therapeutics
YMAB
|
- | - | $ 382 M | Nasdaq Global Select Market,SPB | USA |
 |
Navidea Biopharmaceuticals
NAVB
|
- | -2.99 % | $ 2.47 M | NYSE American | USA |
 |
InMed Pharmaceuticals
INM
|
$ 1.75 | 4.17 % | $ 7.29 M | Nasdaq Capital Market |  Canada |
 |
Stealth BioTherapeutics Corp
MITO
|
- | - | $ 23.9 M | Nasdaq Global Select Market | USA |
 |
Acer Therapeutics
ACER
|
- | 2.71 % | $ 14 M | Nasdaq Capital Market | USA |
 |
Satsuma Pharmaceuticals
STSA
|
- | -0.9 % | $ 36.5 M | Nasdaq Global Market | USA |
 |
Anavex Life Sciences Corp.
AVXL
|
$ 1.25 | 4.58 % | $ 107 M | Nasdaq Capital Market | USA |
 |
SpringWorks Therapeutics
SWTX
|
- | - | $ 3.48 B | Nasdaq Global Select Market,SPB | USA |
 |
Metacrine
MTCR
|
- | - | $ 24.2 M | Nasdaq Global Select Market | USA |
 |
Turning Point Therapeutics
TPTX
|
- | -0.13 % | $ 3.73 B | Nasdaq Global Select Market,SPB | USA |
 |
Ionis Pharmaceuticals
IONS
|
$ 40.14 | -0.69 % | $ 6.42 B | Nasdaq Global Select Market,SPB | USA |
 |
Infinity Pharmaceuticals
INFI
|
- | -46.98 % | $ 3.57 M | Nasdaq Global Select Market | USA |
 |
OncoSec Medical Incorporated
ONCS
|
- | 31.87 % | $ 1.61 M | Nasdaq Global Select Market | USA |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market |  Israel |
 |
Evelo Biosciences
EVLO
|
- | -14.46 % | $ 27.9 M | Nasdaq Global Select Market | USA |
 |
BioDelivery Sciences International
BDSI
|
- | -4.8 % | $ 255 M | Nasdaq Global Select Market | USA |
 |
Morphic Holding
MORF
|
- | - | $ 2.42 B | Nasdaq Global Market | USA |
 |
Novan
NOVN
|
- | -24.84 % | $ 2.64 M | Nasdaq Capital Market | USA |
 |
Genocea Biosciences
GNCA
|
- | -15.0 % | $ 3.04 M | Nasdaq Global Select Market | USA |
 |
Eiger BioPharmaceuticals
EIGR
|
- | -9.21 % | $ 2.55 M | Nasdaq Global Market | USA |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
BELLUS Health
BLU
|
- | - | $ 2.47 B | Nasdaq Global Select Market | Canada |
 |
bluebird bio
BLUE
|
- | - | $ 546 M | Nasdaq Global Select Market,SPB | USA |
 |
Intra-Cellular Therapies
ITCI
|
- | - | $ 13.6 B | Nasdaq Global Select Market,SPB | USA |
 |
IGM Biosciences
IGMS
|
- | - | $ 76.9 M | Nasdaq Global Select Market,SPB | USA |
 |
Marinus Pharmaceuticals
MRNS
|
- | - | $ 29.6 M | Nasdaq Global Select Market | USA |
 |
Merrimack Pharmaceuticals
MACK
|
- | - | $ 216 M | Nasdaq Global Market | USA |
 |
CASI Pharmaceuticals
CASI
|
- | - | $ 35.4 M | Nasdaq Capital Market | USA |
 |
ContraFect Corporation
CFRX
|
- | -5.16 % | $ 5.39 M | Nasdaq Capital Market | USA |
 |
Sigilon Therapeutics
SGTX
|
- | - | $ 728 M | Nasdaq Global Select Market | USA |
 |
Rubius Therapeutics
RUBY
|
- | -33.55 % | $ 7.81 M | Nasdaq Global Select Market | USA |
 |
Aptinyx
APTX
|
- | -39.0 % | $ 4.57 M | Nasdaq Global Select Market | USA |
 |
TRACON Pharmaceuticals
TCON
|
- | -1.38 % | $ 46.8 M | Nasdaq Capital Market | USA |
 |
Mirati Therapeutics
MRTX
|
- | - | $ 3.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Revance Therapeutics
RVNC
|
- | - | $ 309 M | Nasdaq Global Select Market | USA |
 |
Allogene Therapeutics
ALLO
|
$ 1.19 | 5.8 % | $ 263 M | Nasdaq Global Select Market,SPB | USA |
 |
InVivo Therapeutics Holdings Corp.
NVIV
|
- | -37.48 % | $ 476 K | Nasdaq Capital Market | USA |
 |
Epizyme
EPZM
|
- | - | $ 249 M | Nasdaq Global Select Market | USA |